NO20076187L - Fast, transdermalt, terapeutisk system omfattende UV-absorber - Google Patents

Fast, transdermalt, terapeutisk system omfattende UV-absorber

Info

Publication number
NO20076187L
NO20076187L NO20076187A NO20076187A NO20076187L NO 20076187 L NO20076187 L NO 20076187L NO 20076187 A NO20076187 A NO 20076187A NO 20076187 A NO20076187 A NO 20076187A NO 20076187 L NO20076187 L NO 20076187L
Authority
NO
Norway
Prior art keywords
absorber
therapeutic system
layer
transdermal therapeutic
tts
Prior art date
Application number
NO20076187A
Other languages
English (en)
Norwegian (no)
Inventor
Thomas Langguth
Stefan Bracht
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20076187L publication Critical patent/NO20076187L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20076187A 2005-05-02 2007-11-30 Fast, transdermalt, terapeutisk system omfattende UV-absorber NO20076187L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05009579A EP1719504A1 (de) 2005-05-02 2005-05-02 Festes transdermales therapeutisches System mit UV-Absorber
PCT/EP2006/003959 WO2006117139A2 (de) 2005-05-02 2006-04-28 Festes transdermales therapeutisches system mit uv-absorber

Publications (1)

Publication Number Publication Date
NO20076187L true NO20076187L (no) 2007-11-30

Family

ID=34981458

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076187A NO20076187L (no) 2005-05-02 2007-11-30 Fast, transdermalt, terapeutisk system omfattende UV-absorber

Country Status (26)

Country Link
EP (2) EP1719504A1 (ja)
JP (2) JP5360877B2 (ja)
KR (2) KR101426218B1 (ja)
CN (2) CN101171001A (ja)
AR (1) AR055927A1 (ja)
AU (1) AU2006243442A1 (ja)
BR (1) BRPI0611087A2 (ja)
CA (1) CA2605112C (ja)
CR (1) CR9483A (ja)
CY (1) CY1115757T1 (ja)
DK (1) DK1879560T3 (ja)
DO (1) DOP2006000100A (ja)
EA (1) EA200702344A1 (ja)
ES (1) ES2523663T3 (ja)
GT (1) GT200600183A (ja)
IL (1) IL186945A0 (ja)
MX (1) MX2007013779A (ja)
NO (1) NO20076187L (ja)
PE (1) PE20061414A1 (ja)
PL (1) PL1879560T3 (ja)
PT (1) PT1879560E (ja)
SI (1) SI1879560T1 (ja)
TW (1) TW200719902A (ja)
UY (1) UY29511A1 (ja)
WO (1) WO2006117139A2 (ja)
ZA (1) ZA200710418B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004212675B2 (en) 2003-02-21 2006-06-01 Bayer Intellectual Property Gmbh UV stable transdermal therapeutic plaster
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
HUE031326T2 (hu) * 2010-09-06 2017-07-28 Bayer Ip Gmbh Alacsony dózisú transzdermális tapaszok magas hatóanyagleadással

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
ES2081458T3 (es) * 1990-03-30 1996-03-16 Ciba Geigy Ag Composicion de pintura.
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
PT1269999E (pt) * 2000-03-17 2013-06-11 Hisamitsu Pharmaceutical Co Penso com blindagem aos ultravioletas
AU2004212675B2 (en) 2003-02-21 2006-06-01 Bayer Intellectual Property Gmbh UV stable transdermal therapeutic plaster
EP1452173A1 (de) * 2003-02-25 2004-09-01 Schering AG UV-stabiles transdermales Pflaster
MXPA06002754A (es) * 2003-09-11 2006-06-14 Ciba Sc Holding Ag Formas de producto concentrado basado en agua de estabilizadores de luz elaborados por una tecnica de polimerizacion de heterofase.

Also Published As

Publication number Publication date
WO2006117139A2 (de) 2006-11-09
CY1115757T1 (el) 2017-01-25
ZA200710418B (en) 2009-08-26
JP2008540352A (ja) 2008-11-20
IL186945A0 (en) 2008-02-09
MX2007013779A (es) 2008-01-22
PL1879560T3 (pl) 2015-02-27
CR9483A (es) 2008-01-21
PE20061414A1 (es) 2007-01-26
JP2013177451A (ja) 2013-09-09
EA200702344A1 (ru) 2008-12-30
AU2006243442A1 (en) 2006-11-09
EP1879560A2 (de) 2008-01-23
EP1879560B1 (de) 2014-08-27
DOP2006000100A (es) 2007-01-31
PT1879560E (pt) 2014-11-19
CN108969507A (zh) 2018-12-11
KR101351161B1 (ko) 2014-01-14
GT200600183A (es) 2007-01-03
EP1719504A1 (de) 2006-11-08
AR055927A1 (es) 2007-09-12
WO2006117139A3 (de) 2007-04-19
JP5360877B2 (ja) 2013-12-04
KR20130099203A (ko) 2013-09-05
KR101426218B1 (ko) 2014-08-05
SI1879560T1 (sl) 2015-01-30
KR20080003854A (ko) 2008-01-08
DK1879560T3 (en) 2014-11-24
CA2605112C (en) 2013-11-05
TW200719902A (en) 2007-06-01
CA2605112A1 (en) 2006-11-09
UY29511A1 (es) 2006-08-31
CN101171001A (zh) 2008-04-30
BRPI0611087A2 (pt) 2010-08-03
ES2523663T3 (es) 2014-11-28

Similar Documents

Publication Publication Date Title
Cheang et al. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice
Pereira et al. Memory impairment induced by sodium fluoride is associated with changes in brain monoamine levels
ES2599802T3 (es) Sistema de administración transdérmica
HRP20050828A2 (en) Uv stable transdermal therapeutic plaster
AR097045A2 (es) Sistema terapéutico transdérmico
MA28921B1 (fr) Derive heterocyclique azote et medicament le contenant en tant que principe actif
Strupp et al. Pharmacotherapy of vestibular and cerebellar disorders and downbeat nystagmus: Translational and back‐translational research
Trenkwalder et al. A placebo‐controlled trial of AQW051 in patients with moderate to severe levodopa‐induced dyskinesia
NO20076187L (no) Fast, transdermalt, terapeutisk system omfattende UV-absorber
WO2022038475A1 (en) Pharmaceutical compositions and methods for treating parkinson's disease
BRPI0507645A (pt) anticorpo, método de detectar um distúrbio ósseo metabólico, kit para detectar um distúrbio ósseo metabólico, composição farmacêutica para o tratamento de um distúrbio ósseo metabólico, e, método de triar uma substáncia efetiva para tratar e/ou prevenir um distúrbio ósseo metabólico
BR0212026A (pt) Sistema terapêutico transdérmico com fentanila ou substâncias análogas
Mijailovic et al. Effects of nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling
Cruz et al. Stress-induced cross-sensitization to amphetamine is related to changes in the dopaminergic system
Soeiro‑de‑Souza et al. Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders
AU2008228903B2 (en) Transdermal patch and method for delivery of vitamin B12
Hondebrink et al. High concentrations of MDMA (‘ecstasy’) and its metabolite MDA inhibit calcium influx and depolarization-evoked vesicular dopamine release in PC12 cells
Walker et al. Cerebral and skeletal muscle feed artery vasoconstrictor responses in a mouse model with greater large elastic artery stiffness
Zhang et al. TRPV1 is involved in the antinociceptive effects of resveratrol in paclitaxel-induced neuropathic pain
Cilurzo et al. Formulation study of a patch containing propranolol by design of experiments
BR112012014107A2 (pt) sistema terapêutico transdérmico para administração de peptídeos
Milton et al. Adenosine and ATP-sensitive potassium channels modulate dopamine release in the anoxic turtle (Trachemys scripta) striatum
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente
Sable et al. Antipsychotic treatment for late-life schizophrenia
Mazzone et al. Topiramate in children with autistic spectrum disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application